Diplomat Pharmacy, Inc. (NYSE:DPLO) has analysts on the Bullish side this week.

October 13, 2018 - By Ruchi Gupta

Diplomat Pharmacy, Inc. (NYSE:DPLO) LogoInvestors sentiment increased to 1.16 in Q2 2018. Its up 0.16, from 1 in 2018Q1. It improved, as 26 investors sold Diplomat Pharmacy, Inc. shares while 56 reduced holdings. 33 funds opened positions while 62 raised stakes. 58.46 million shares or 6.80% more from 54.74 million shares in 2018Q1 were reported.
First Allied Advisory Ser Inc stated it has 0.01% of its portfolio in Diplomat Pharmacy, Inc. (NYSE:DPLO). State Teachers Retirement Sys reported 0% stake. Weiss Multi holds 20,000 shares. Palisade Management Ltd Company Nj invested in 506,783 shares or 0.37% of the stock. X Co Ltd Limited Liability Company holds 0% of its portfolio in Diplomat Pharmacy, Inc. (NYSE:DPLO) for 1,913 shares. Vanguard Grp Inc Inc invested 0.01% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Brown Brothers Harriman Co stated it has 4,500 shares. Strs Ohio invested in 0% or 41,300 shares. Numerixs Inv Techs holds 1,199 shares. The Illinois-based Citadel Advisors Ltd Liability Company has invested 0% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Moreover, California State Teachers Retirement Sys has 0% invested in Diplomat Pharmacy, Inc. (NYSE:DPLO) for 86,879 shares. Tower Cap Ltd Llc (Trc) owns 0.01% invested in Diplomat Pharmacy, Inc. (NYSE:DPLO) for 5,700 shares. Pub Employees Retirement Sys Of Ohio holds 47,905 shares or 0.01% of its portfolio. Manufacturers Life The reported 42,407 shares or 0% of all its holdings. Dimensional Fund Advsrs Limited Partnership reported 0.01% stake.

Since May 23, 2018, it had 0 insider buys, and 8 insider sales for $6.22 million activity. $1.68M worth of Diplomat Pharmacy, Inc. (NYSE:DPLO) was sold by Hagerman Philip R. 1,680 shares were sold by KLEPPER KENNETH O, worth $40,767. Tomasello Shawn sold $40,766 worth of stock or 1,680 shares. 1,679 Diplomat Pharmacy, Inc. (NYSE:DPLO) shares with value of $40,744 were sold by Wolin Benjamin. 1,680 shares valued at $40,765 were sold by Benjamin Regina M. on Friday, June 1.

Diplomat Pharmacy, Inc. (NYSE:DPLO) Ratings Coverage

Among 4 analysts covering Diplomat Pharmacy (NYSE:DPLO), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Diplomat Pharmacy had 4 analyst reports since May 10, 2018 according to SRatingsIntel. The rating was upgraded by J.P. Morgan on Thursday, May 10 to “Buy”. Morgan Stanley maintained the shares of DPLO in report on Tuesday, July 3 with “Equal-Weight” rating. JP Morgan upgraded Diplomat Pharmacy, Inc. (NYSE:DPLO) on Thursday, May 10 to “Overweight” rating. The company was maintained on Friday, June 22 by Leerink Swann. Below is a list of Diplomat Pharmacy, Inc. (NYSE:DPLO) latest ratings and price target changes.

03/07/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $16 New Target: $21 Maintain
22/06/2018 Broker: Leerink Swann Rating: Buy New Target: $33.0000 Maintain
10/05/2018 Broker: J.P. Morgan Rating: Buy New Target: $27.0000 Upgrade
10/05/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Overweight Upgrade

The stock increased 1.38% or $0.25 during the last trading session, reaching $18.31. About 707,228 shares traded. Diplomat Pharmacy, Inc. (NYSE:DPLO) has risen 4.25% since October 13, 2017 and is uptrending. It has underperformed by 11.37% the S&P500.

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company has market cap of $1.36 billion. The firm stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It has a 416.14 P/E ratio. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems.

More news for Diplomat Pharmacy, Inc. (NYSE:DPLO) were recently published by: Prnewswire.com, which released: “Diplomat Opens Facility in Arizona” on September 27, 2018. Globenewswire.com‘s article titled: “Market Trends Toward New Normal in Diplomat Pharmacy, Senior Housing Properties Trust, FARO Technologies …” and published on October 09, 2018 is yet another important article.

Diplomat Pharmacy, Inc. (NYSE:DPLO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>